Related Experiment Video
Updated: May 1, 2026
07:58
Formulation and Characterization of Bioactive Agent Containing Nanodisks
Published on: March 17, 2023
1.8K
DNA nanotechnology-based development of delivery systems for bioactive compounds
Kohta Mohri1, Makiya Nishikawa1, Yuki Takahashi1
1Department of Biopharmaceutics and Drug Metabolism, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
Summary
DNA nanotechnology enables the creation of novel delivery systems. Precisely designed DNA nanostructures enhance the immune activity of CpG DNA, a potent immune stimulant.
Area of Science:
- Biotechnology
- Nanotechnology
- Immunology
Background:
- Nucleic acids like DNA and RNA carry genetic information and act as immune danger signals.
- DNA nanotechnology utilizes DNA's properties to build nanoscale structures.
- These DNA nanostructures offer potential for programmable delivery systems.
Purpose of the Study:
- To review recent advancements in DNA nanotechnology.
- To explore applications of DNA nanostructures as delivery systems.
- To focus on the delivery of CpG DNA motifs to immune cells.
Main Methods:
- Summarizing recent research in DNA nanotechnology.
- Investigating the use of DNA nanoconstructs for delivering bioactive compounds.
- Analyzing the enhancement of CpG DNA activity using various DNA nanostructures.
Main Results:
- DNA nanostructures can be precisely designed for specific functions.
- Advanced DNA constructs like DNA origami can improve CpG DNA delivery.
- These nanostructures enhance the biological activity of CpG DNA.
Conclusions:
- DNA nanotechnology provides a powerful platform for developing advanced delivery systems.
- Engineered DNA nanostructures can significantly boost the therapeutic potential of CpG DNA.
- This field holds promise for targeted immune stimulation and drug delivery.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
01:23Oral Drug Delivery Systems: Introduction
279
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
279
01:30Modified-Release Drug Delivery Systems: Bioavailability
170
Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
170
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
01:27Drug Delivery Systems: Different Types
406
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
406